All In Biotech

Free tool

FAERS Monitor: Endari

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208587 or its brand name (Endari, L-Glutamine). Reports on generic versions are filed under their own applications.

Reports

4,606

Serious

2,873

62% of reports

Hospitalization

1,759

Death reported

128

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • sickle cell anaemia with crisis1,751
  • product dose omission issue723
  • pain281
  • product dose omission272
  • nausea241
  • headache214
  • hospitalisation212
  • diarrhoea201
  • abdominal pain upper160
  • constipation152
  • fatigue150
  • drug dose omission132
  • pain in extremity130
  • emergency care128
  • back pain127

Reports by year received

View as table
YearReports
200414
200518
20066
20077
200810
20097
201018
201117
201232
201322
201428
201547
201688
201796
2018781
2019608
2020439
2021260
2022352
2023456
2024707
2025361
2026232

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,553 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sickle cell anaemia with crisisSignal1,751570.6548.0885,269
emergency careSignal128201.2169.024,238
product dose omissionSignal27219.117.04,643
product dose omission issueSignal72311.310.56,822
hospitalisationSignal2126.35.5947
drug dose omissionSignal1323.63.1253
abdominal pain upperSignal1603.63.0293
constipationSignal1523.22.7228
back painSignal1272.52.1114
painSignal2812.11.9163
pain in extremitySignal1302.01.766
headache2141.61.444
diarrhoea2011.41.226
nausea2411.41.227
fatigue1500.90.82

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.